Stocks End Mixed as Geopolitical Risk Outweighs Tech Gains

U.S. equity markets ended the month on an uneven note Monday, with broad-based weakness in defensive and cyclical sectors offsetting gains in energy and select financial services plays. The S&P 500 declined 0.30% to 767.05, the Dow Jones fell 0.65% to 531.57, and the Russell 2000 slipped 0.62% to 293.93, while the Nasdaq 100 managed a marginal 0.05% gain at 716.76—a sign that growth-oriented investors found limited refuge in technology stocks.

Geopolitics and Energy Lead the Action

Escalating U.S.-Iran hostilities near the Strait of Hormuz drove energy prices higher, lifting the sector 1.07% on the day. Oil-sensitive equities rallied as markets priced in a geopolitical risk premium, a dynamic that will likely persist through September—historically the market's most volatile month. Citadel's recent commentary on compelling risk-reward in equity protection signals institutional investors are taking these tensions seriously.

Contrary to energy's strength, healthcare and consumer sectors stumbled. Healthcare declined 0.44% amid fallout from the Trump administration's drug pricing negotiations with nine major pharmaceutical companies, requiring U.S. Medicaid to match the lowest international prices. Consumer Cyclical stocks fell 1.30%, the session's worst-performing sector, reflecting broader concerns about consumer resilience as macro headwinds build.

Financial Services Paradox: Individual Gainers, Sector Decline

Among the day's most intriguing moves, four financial services stocks posted double-digit gains—ASST (+11.4%), TSLL (+11.0%), CRCL (+9.7%), and XSPIX (+8.8%)—yet the sector as a whole declined 0.35%. This divergence suggests rotation within financials rather than broad-based strength, possibly reflecting positioning ahead of potential Fed policy shifts. Fed Chair Warsh's recent signal of a shift from global savings glut toward an investment surge may be underpinning selective positioning in financial plays.

Earnings Signals Mixed Confidence

SY delivered a notable earnings beat with EPS surging 66% year-over-year, though revenue growth stalled at flat, raising questions about margin expansion sustainability. Elsewhere, FI faced a brutal downgrade to a $53 price target—a 17% cut—following a 14.2% EPS guidance reduction to $7.41 and an organic growth outlook slashed to -1%. Such guidance cuts typically presage further sector weakness.

Looking Ahead: September and Structural Headwinds

With August behind us, September looms with elevated volatility expectations and multiple structural headwinds in play: geopolitical risk, drug pricing pressure on healthcare, and Fed policy recalibration. Fed Chair Warsh's comments on capital reallocation suggest growth opportunities may shift toward higher-yielding, capital-intensive sectors—potentially benefiting energy and industrials if geopolitical risk premiums persist.

On the bullish side, the Medicare GLP-1 program's rapid uptake—600,000 seniors in two months—signals robust demand for weight-loss therapies, offering a bright spot for select healthcare names positioned to benefit from this secular trend.

Several stocks with converging bullish signals merit attention: SQM, ADI (both with 3 convergent signals), FRO, PAHC, and CMBT. However, investors should navigate this month with caution given geopolitical uncertainty and earnings guidance cuts signaling operational headwinds.